1/33
Antimicrobial drugs
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Selective toxicity
selectively finding and destroying pathogens without damaging the host
Chemotherapy
the use of chemicals to treat a disease
Antimicrobial drugs
substances that in small maounts kill or inhibit the growth of microbes, including bacteria, fungi, viruses, and parasites
Antibiotics
specific type of antimicrobial drug that target bacteria
Narrow-spectrum
drugs that affect a narrow range of microbial types
Isoniazid: mycobacteria (prokaryotes)
Ketoconazole: fungi (eukaryotes)
Mefloquine (malaria): protozoa (eukaryotes)
Acyclovir: viruses (herpes)
broad-spectrum
affect a broad range of gram-positive or gram-negative bacteria
Streptomycin: mycobacteria + gram-negative bacteria (prokaryotes)
Tetracycline: gram-negative, gram-positive, chlamydias rickettisias (prokaryotes)
Superinfection
overgrowth (flourish) of an opportunistic pathogen when the normal microbiota are disrupted, typically due to antibiotic use
Bacteriostatic
an agent or substance that inhibits growth without killing
Ex. tetracyclines
bactericidal
an agent or substance that kills bacteria
ex. penicillin, cephalosporins
Antibacterial drug actions: Inhibition of cell wall synthesis
Prevents the synthesis of peptidoglycan
Generally safe and effective (can have side effects)
Penicillins, cephalosporins, bacitracin, vancomycin
Antibacterial drug actions: inhibition of protein synthesis
Target bacterial 70S ribsomes (not free ribsomes which are 80S)
Has side effects
Chloramphenicol, erythromycin, streptomycin, tetracyclines
Antibacterial drug actions: inhibition of nucleic acid replication and transcription
Can have some effects
Quinolones: block topoisomerase (interferes with DNA replication)
Rifampin: block RNA polymerase (interferes with transcription)
Antibacterial drug actions: injury to plasma membrane
Polypeptide antibiotics change membrane permeability
antifungal drugs combine w/ membrane sterols
have side effects
Polymyxin B
Antimicrobial drug actions: inhibition of essential metabolite synthesis
Antimetabolites compete with normal substrates for an enzyme
Sulfanilamide: competes with para-aminobenzoic acid (PABA), stopping synthesis of folic acid
Can have some efefcts
sulfanilamide, trimethoprim
Antifungal (ergosterol)
Ketoconazole —> systemic fungal infections
Clotrimazole —> topical use
Antiprotozoan drugs
Chloroquine/mefloquine —> treats malaria
Metronidazole —> used to treat giardisis, amebiasis, trichomoniasis
“d” for anti-parasite
Antihelminthic drugs
Mebendazole/albendazole —> inhibit absorption of nutrients, intestinal roundworms
Antiviral drugs
Acyclovir: treats herpes infection (nucleic acid synthesis inhibitor)
Oseltamivir: treats influenza virus (inhibits NA spike)
ends with “vir”
Penicillin (inhibition of cell wall synthesis)
Prevents cross-linking of peptidoglycan, interfering with cell wall
Contains beta-lactam ring (types depend on side chains)
Natural penicillin, Semisynthetic penicillin
Natural Penicillin
Extracted from Penicillium fungi
Narrow spectrum of activity susceptible to penicillinases
Penicillin G —> requires injection
Penicillin V —> can be taken orally
Semisynthetic penicillins
Contains chemically added side chains
oxacillin: narrow spectrum, only gram-positive, but resistant to penicillinase
Ampicillin: extended spectrum, many gram-negatives
Penicillin categories
Penicillinase-resistant
methicillin and oxacillin
Broad-spectrum (effective against gram-positive/negative)
Amoxicillin/Clavulanate
Penicillins plus penicillinase inhibitors
Contain clavulanic acid, a noncompetitive inhibitor of penicillinase —> makes them more effective against bacteria that produce enzymes capable of destroying penicillin
Penicillinase (beta-lactam lactamase)
an enzyme produced by some bacteria that destroys penicillin
breaks the beta-lactam ring in penicillin
can no longer bind to its enzyme in bacteria, making it ineffective
Cephalosporins
work similar to penicillins but has different beta-lactam ring
grouped according to their generation of development
Disk-diffsion method (kirby-bauer test)
tests for effectiveness of chemotherapeutic agents
paper disks placed with chemotherapeutic agent on agar w/ organism
Zone of inhibition: determines the susceptibility of the organism to the antibiotic
Epsilometer test (E test)
a gradient diffusion method that determines antibiotic sensitivity and estimates the MIC
lowest antibiotic concentration preventing bacterial growth
Broth dilution tests
determines the MIC and MBC of an antimicrobial drug
test organism is placed into the wells of a tray containing dilutions of a drug
subculture is used to determine whether bacteria have been killed or only inhibited
lowest lethal concentration that kills the bacteria is MBC
Resistance to antimicrobial drugs
Superbugs: bacteria that are resistant to multiple antibiotics making them difficult to treat
resistant genes are spread horizontally among bacteria on plasmids or transposons
Resistant pathogens to antibiotics
Acinetobacter baumannii
Pseudomonas aeruginosa
Some members of the enterobactiaceae
Mechanisms of resistance
Ezymatic destruction or inactivation of the drug
Prevention of penetration to the target site within the microbe
Alteration of the drug’s target site
Rapid efflux of the antibiotic
Variations of mechanisms of resistance
Misuse of antibiotics
Failing to complete the prescribed regiment (most detrimental)
Availability of antibiotics w/o prescriptions in some countries
Using outdated or weakened antibiotics
Using antibiotics for the common cold and other inappropriate conditions
Using antbiotics in animal feed
Using someone else’s leftover prescription
Synergism
the effect of two drugs together is greater than the effect of either alone
penicillin and streptomycin are more effective when taken together in some situations
Antagonism
the effect of two drugs together is less than the effect of either alone
tetracycline sometimes interferes with the activity of penicillin
(Future) Antimicrobial peptides: Bacteriocins
antimicrobial peptides produced by bacteria to inhibit the growth of closely related or competitive bacterial strains
Future of antimicrobial agents: Phage therapy
using bacteriophage to treat infections